Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0000899243-18-011132

Director sold 30,566 shares at an average $50.29 ($1,537,138)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Bolzon Bradley J PhD Director 2018-04-30 Sale −26,860 $50.29 $1,350,789 1,297,334 I
Bolzon Bradley J PhD Director 2018-04-30 Sale −788 $50.29 $39,629 38,064 I
Bolzon Bradley J PhD Director 2018-04-30 Sale −874 $50.26 $43,927 42,193 I
Bolzon Bradley J PhD Director 2018-04-30 Sale −2,044 $50.29 $102,793 98,736 I
Open-market sales · 30,566 sh · avg $50.29 · $1,537,138
Loading xslF345X03/doc4.xml…